KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Discontinued OperationsCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Change in Intangibles (2016 - 2022)

TherapeuticsMD's Change in Intangibles history spans 11 years, with the latest figure at $95000.0 for Q4 2022.

  • For Q4 2022, Change in Intangibles fell 93.73% year-over-year to $95000.0; the TTM value through Dec 2022 reached $355000.0, down 83.78%, while the annual FY2022 figure was $355000.0, 83.78% down from the prior year.
  • Change in Intangibles reached $95000.0 in Q4 2022 per TXMD's latest filing, up from -$7000.0 in the prior quarter.
  • In the past five years, Change in Intangibles ranged from a high of $1.5 million in Q4 2021 to a low of -$7000.0 in Q3 2022.
  • Average Change in Intangibles over 5 years is $324120.4, with a median of $309762.0 recorded in 2018.
  • Peak YoY movement for Change in Intangibles: soared 364.42% in 2021, then tumbled 102.78% in 2022.
  • A 5-year view of Change in Intangibles shows it stood at $356501.0 in 2018, then increased by 4.76% to $373458.0 in 2019, then decreased by 12.71% to $326000.0 in 2020, then skyrocketed by 364.42% to $1.5 million in 2021, then crashed by 93.73% to $95000.0 in 2022.
  • Per Business Quant, the three most recent readings for TXMD's Change in Intangibles are $95000.0 (Q4 2022), -$7000.0 (Q3 2022), and $97000.0 (Q2 2022).